Being Singapore’s first public listed TCM company since 2000, Eu Yan Sang has modernised TCM to meet today’s lifestyle and to keep its brand relevant. Much of the company’s strength is in its constant pursuit in research and development of TCM products as well as maintaining quality products through a scientific approach such as Fingerprinting of raw herbs to assure consistency in its efficacy.
"Our goal is to make TCM accessible to a broader and larger audience. We currently have a presence in Hong Kong, China, Singapore, Malaysia, Australia and the USA. We epitomise the advantages of being Singaporean, in that we can relate to East and West. This will also help internationalise the EYS brand and grow our brand value beyond what it is today." – Mr. Richard Eu, Group CEO
Financial Highlights
View our turnover, EBITDA, earnings per share, NTA per share, dividends per share and shareholder equity.
Investors 
